Alan vs Hippocratic AI
In-depth comparison — valuation, funding, investors, founders & more
🇫🇷 France · Jean-Charles Samuelian
Valuation
$1.4B
Total Funding
$220M
500-1000 employees
🇺🇸 United States · Munjal Shah
Valuation
N/A
Total Funding
$120M
50-200 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Alan and Hippocratic AI compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up.
Alan carries a known valuation of $1.4B, while Hippocratic AI's valuation has not been publicly disclosed. On the funding side, Alan has raised $220M in total — $100M more than Hippocratic AI's $120M.
Alan has 7 years more market experience, having been founded in 2016 compared to Hippocratic AI's 2023 founding. In terms of growth stage, Alan is at Series D while Hippocratic AI is at Series B — a meaningful difference for investors evaluating risk and upside.
Alan operates out of 🇫🇷 France while Hippocratic AI is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, Alan leads with a score of 83, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Alan | Hippocratic AI |
|---|---|---|
💰Valuation | $1.4B | N/A |
📈Total Funding | $220MWINS | $120M |
📅Founded | 2016 | 2023WINS |
🚀Stage | Series D | Series B |
👥Employees | 500-1000 | 50-200 |
🌍Country | France | United States |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 83WINS | 65 |
Key Differences
Funding gap: Alan has raised $100M more ($220M vs $120M)
Market experience: Alan has 7 years more (founded 2016 vs 2023)
Growth stage: Alan is at Series D vs Hippocratic AI at Series B
Team size: Alan has 500-1000 employees vs Hippocratic AI's 50-200
Market base: 🇫🇷 Alan (France) vs 🇺🇸 Hippocratic AI (United States)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Alan scores 83/100 vs Hippocratic AI's 65/100
Which Should You Choose?
Use these signals to make the right call
Choose Alan if…
Top Pick- ✓Higher Awaira Score — 83/100 vs 65/100
- ✓More established by valuation ($1.4B)
- ✓Stronger investor backing — raised $220M
- ✓More market experience — founded in 2016
- ✓France-based for regional compliance or proximity
- ✓Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
Choose Hippocratic AI if…
- ✓United States-based for regional compliance or proximity
- ✓Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up